• No image available for this medication
    • IDHIFA

    • QTY 30
    • 50 MG
    • Tablet
    • Near  77381

ENASIDENIB (EN a SID e nib) treats leukemia. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.


IDHIFA Lifestyle Interactions

  • Enasidenib 50mg, Oral tablet

    Interaction: Caffeine-containing Foods/Beverages
    Severity: Major
    Notes for Consumers: Do not drink caffeine or eat foods containing caffeine while taking this medication. Serious side effects may occur. Contact your care team right away if you experience a fast or irregular heartbeat.
    Notes for Professionals: Advise patients to avoid or minimize caffeine consumption during enasidenib treatment due to the risk for increased caffeine exposure which may increase the risk for caffeine-related adverse reactions, such as nervousness, irritability, insomnia, tachycardia, and tremor. Caffeine is a CYP1A2 substrate and enasidenib is a CYP1A2 inhibitor.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.